Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zeitler

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Molecular Endocrinology (Baltimore, Md.)|April 15, 2006
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinaseG Siriwardana, A Bradford, D Coy, et al.
Endocrinology|December 1, 1993
Impaired growth hormone-releasing hormone signal transduction in the dwarf (dw) rat is independent of a generalized defect in the stimulatory G-protein, Gs alphaP Zeitler, T R Downs, L A Frohman
The Yale Journal of Biology and Medicine|April 3, 2023
Arrhythmias After Acute Myocardial InfarctionJennifer Frampton, Alexandra R Ortengren, Emily P Zeitler
Circulation. Cardiovascular Quality and Outcomes|October 31, 2023
Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?Emily P Zeitler, Derek S Chew, Daniel B Mark
Cardiac Electrophysiology Clinics|October 26, 2024
ForewordLuigi Di Biase, Emily P Zeitler, Kenneth A Ellenbogen
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
The Impact of the Medical Device Directive to Medical Device Regulation Transition on Early Clinical Testing of Cardiovascular DevicesAdam J Prince, Emily P Zeitler, Aaron V Kaplan
JAMA Internal Medicine|November 11, 2024
Consumer Wearables-Advancing Atrial Fibrillation Care or Too Much Information?Derek S Chew, Emily P Zeitler, Daniel B Mark
The American Journal of Cardiology|April 22, 2026
Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future DirectionsKristen B Campbell, Jagmeet P Singh, Emily P Zeitler
Current Cardiology Reports|May 31, 2022
Subcutaneous and Transvenous ICDs: an Update on Contemporary Questions and ControversiesDaniel J Friedman, Albert S Tully, Emily P Zeitler
JACC. Heart Failure|October 29, 2021
How Is Medical Device Innovation Currently Supported in the U.S.?: From the Heart Failure CollaboratoryEmily P Zeitler, Christopher M O'Connor, William Abraham, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Molecular Endocrinology (Baltimore, Md.)|April 15, 2006
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinaseG Siriwardana, A Bradford, D Coy, et al.
Endocrinology|December 1, 1993
Impaired growth hormone-releasing hormone signal transduction in the dwarf (dw) rat is independent of a generalized defect in the stimulatory G-protein, Gs alphaP Zeitler, T R Downs, L A Frohman
The Yale Journal of Biology and Medicine|April 3, 2023
Arrhythmias After Acute Myocardial InfarctionJennifer Frampton, Alexandra R Ortengren, Emily P Zeitler
Circulation. Cardiovascular Quality and Outcomes|October 31, 2023
Opportunistic Screening for Subclinical Atrial Fibrillation: It Is Cost-Effective, but Is It Effective?Emily P Zeitler, Derek S Chew, Daniel B Mark
Cardiac Electrophysiology Clinics|October 26, 2024
ForewordLuigi Di Biase, Emily P Zeitler, Kenneth A Ellenbogen
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
The Impact of the Medical Device Directive to Medical Device Regulation Transition on Early Clinical Testing of Cardiovascular DevicesAdam J Prince, Emily P Zeitler, Aaron V Kaplan
JAMA Internal Medicine|November 11, 2024
Consumer Wearables-Advancing Atrial Fibrillation Care or Too Much Information?Derek S Chew, Emily P Zeitler, Daniel B Mark
The American Journal of Cardiology|April 22, 2026
Antiarrhythmic Drugs for Rhythm Control of Atrial Fibrillation: Unmet Needs and Future DirectionsKristen B Campbell, Jagmeet P Singh, Emily P Zeitler
Current Cardiology Reports|May 31, 2022
Subcutaneous and Transvenous ICDs: an Update on Contemporary Questions and ControversiesDaniel J Friedman, Albert S Tully, Emily P Zeitler
JACC. Heart Failure|October 29, 2021
How Is Medical Device Innovation Currently Supported in the U.S.?: From the Heart Failure CollaboratoryEmily P Zeitler, Christopher M O'Connor, William Abraham, et al.
Pageof 18